Avoid common mistakes on your manuscript.
Correction to: Dermatol Ther (Heidelb) (2023) 13:1361–1376 https://doi.org/10.1007/s13555-023-00933-z
Authors would like to add the list of all investigators who took part in the study as supplementary material.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Jullien, D., Richard, MA., Halioua, B. et al. Correction to: The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study. Dermatol Ther (Heidelb) 13, 2127 (2023). https://doi.org/10.1007/s13555-023-00976-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13555-023-00976-2